Vanguard Fiduciary Trust
CABA icon

Vanguard Fiduciary Trust’s Cabaletta Bio CABA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Buy
1,088,595
+518,404
+91% +$1.7M ﹤0.01% 2406
2026
Q1 		$1.53M Buy
+570,191
New +$1.58M ﹤0.01% 2708

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Fiduciary Trust's CABA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Cabaletta Bio (CABA) stake by 91% in Q2 2026, buying an estimated $1.7M and bringing the position to 1,088,595 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

Vanguard Fiduciary Trust first reported a position in CABA in Q1 2026 and has held it in 2 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,088,595 shares of Cabaletta Bio worth $3.39M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 518,404 Cabaletta Bio shares in Q2 2026, an estimated $1.7M.
  • Cabaletta Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2406 holding.
  • Vanguard Fiduciary Trust first reported a position in Cabaletta Bio in Q1 2026 and has held it in 2 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.